SCHEMBL30659714

SCHEMBL30659714

C[C@H](N)C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@@H](C)O

nearest known ligand 0.66

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CAPN1 P07384 2/20 0.66
▸ CTSB P07858 2/20 0.66
▸ DPP3 Q9NY33 5/20 0.60
▸ CXCL8 P10145 5/20 0.48
▸ F13A1 P00488 1/20 0.47
▸ TGM2 P21980 1/20 0.47
▸ NTSR2 O95665 1/20 0.47
▸ NTSR1 P30989 1/20 0.47
▸ SORT1 Q99523 1/20 0.47
▸ TACR2 P21452 1/20 0.47
▸ ACE P12821 1/20 0.46
▸ KISS1R Q969F8 2/20 0.46
▸ OPRM1 P35372 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29370211 0.83 CAPN1 (0.64) CAPN1CTSBDPP3F13A1TGM2
SCHEMBL30052964 0.83 DPP3 (0.69) CAPN1CTSBDPP3NTSR2NTSR1
SCHEMBL31499421 0.82 DPP3 (0.60) CAPN1CTSBDPP3CXCL8NTSR2
SCHEMBL29437938 0.82 CAPN1 (0.61) CAPN1CTSBDPP3CXCL8F13A1
SCHEMBL31362650 0.82 CAPN1 (0.64) CAPN1CTSBDPP3CXCL8NTSR2
SCHEMBL31362653 0.82 CAPN1 (0.62) CAPN1CTSBDPP3CXCL8NTSR2
SCHEMBL30051406 0.81 DPP3 (0.58) CAPN1CTSBDPP3ACE
SCHEMBL9728122 0.81 CAPN1 (0.64) CAPN1CTSBDPP3NTSR2NTSR1
SCHEMBL30921661 0.81 NTSR2 (0.55) CAPN1CTSBDPP3F13A1TGM2
SCHEMBL31070712 0.81 DPP3 (0.69) CAPN1CTSBDPP3CXCL8NTSR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532513-A1 CYCLIC PEPTIDES WITH ANTIBACTERIAL ACTIVITY AGAINST MULTIDRUG RESISTANT (MDR) PATHOGENS Fundación Privada Instituto De Salud Global Barcelona (ES) 2025-04-09 — — EP disclosed
CN-119451974-A Cyclic peptides having antibacterial activity against Multiple Drug Resistant (MDR) pathogens 巴塞罗那全球健康研究所私人基金会 2025-02-14 — — CN disclosed
WO-2023227771-A1 CYCLIC PEPTIDES WITH ANTIBACTERIAL ACTIVITY AGAINST MULTIDRUG RESISTANT (MDR) PATHOGENS Fundación Privada Instituto De Salud Global Barcelona (ES) 2023-11-30 — — WO disclosed
Send feedback